Bart Hofsté
Cancer Immunotherapy Part II: its state-of-the-art and future promise
MedischCancer Immunotherapy Part II: its state-of-the-art and future promise
Cancer immunotherapy: its history, state-of-the-art, and future promise
MedischCAR-T cells, oncolytic viruses, cytokine therapies, antibody therapies… The list of immune therapies seems to be ever expanding. With the 2018 Nobel prize going to the discoverers of immune checkpoint inhibitors, the topic of cancer immunotherapy seems hotter than ever. Are you interested to explore some of the landmarks in the history of cancer immunotherapy, to discover the state of the art today, and to see what lies in store in the future? If so, then read on…
Patiëntcolumn: ervaringen van de andere kant
ColumnHet gaat precies zoals men zegt. De grond verdwijnt onder je voeten, de klok staat even stil.
Liability law
MedischHow careful are you?